Perfil
Dakota Gallivan es Director de Cumplimiento Sanitario y Vicepresidente de Reata Pharmaceuticals, Inc. Anteriormente, el Sr. Gallivan ocupó el cargo de Consejero de Cumplimiento en Pharmacyclics LLC. El Sr. Gallivan se licenció en el St. Francis College y se graduó en la Facultad de Derecho de la Universidad de Seton Hall.
Antiguos cargos conocidos de Dakota Gallivan.
| Empresas | Cargo | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26/09/2023 |
| DERMIRA, INC. | General Counsel | 01/01/2020 |
| PHARMACYCLICS, INC. | General Counsel | 01/04/2018 |
| Medivation, Inc. /Old/ | General Counsel | 01/04/2017 |
| PFIZER, INC. | General Counsel | 01/04/2017 |
Formación de Dakota Gallivan.
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Bolsa de valores
- Insiders
- Dakota Gallivan
